We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 221

Application to amend inventorship allowed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • February 6 2013

By this application, Sega sought an Order amending the named inventors of a patent. The application was uncontested by the respondent who did not file

Court of Appeal upholds decision relating to sildenafil use patent

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

Pfizer Ireland Pharmaceuticals v. Apotex Inc., 2014 FCA 13 Drug: VIAGRA sildenafil In Apotex' action for impeachment of the Pfizer patent

Antibody patent found valid and infringed

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 27 2014

The Court recently decided a patent infringement case dealing with antibodies. The claims at issue in AbbVie’s patent relate to the use of a human

Allegations as to non-infringement of Form I held to be justified

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2014

Teva asserted both non-infringement and invalidity in its Notice of Allegation. The Court noted that invalidity of this patent had been before it

Judicial review brought outside time period and no vested right to NOC

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This decision relates to the consideration by the Minister of Health of Apotex’ submission for a Notice of Compliance (NOC) for omeprazole magnesium

Definition of “innovative drug” does not include variations

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This is an appeal by Takeda of a decision of the Court, in which the Court upheld the decision of the Minister of Health to refuse to list Takeda’s

Trial Judge's findings of anticipation and obviousness upheld on appeal

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • January 23 2013

This is an appeal of a patent infringement decision. The Court found the patent invalid for anticipation and obviousness. The Court of Appeal held

Patent to an “expandable and contractible hose” found to be obvious

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • April 16 2014

One of the plaintiffs in this patent infringement suit is the inventor of Canadian Patent No. 2,779,882, a patent that claims a compact garden hose

Pfizer Canada Inc. v. Novopharm, The Minister of Health, Northwestern University and the Board of Regents for the University of Oklahoma

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

In a proceeding pursuant to the Patented Medicines (Notice of Compliance) Regulations, Novopharm brought a motion seeking a Protective Order that allowed the designation of Novopharm's Notice of Allegation (NOA) as confidential

Wenzel Downhole Tools et al. v. National-Oilwell Canada et al.

  • Borden Ladner Gervais LLP
  • -
  • Canada
  • -
  • July 5 2010

This is a patent infringement action